Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

3 Pot Growers Poised To Profit From The State-By-State March To Legalization

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsJul 28, 2020 04:55
ca.investing.com/analysis/3-pot-growers-poised-to-profit-from-the-statebystate-march-to-legalization-200438740
3 Pot Growers Poised To Profit From The State-By-State March To Legalization
By Investing.com (Brenda O'Farrell/Investing.com)   |  Jul 28, 2020 04:55
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

As the cannabis industry continues to wait for legalization of recreational marijuana on a national level in the US, analysts are keeping close watch on the next best thing—which states will be added to the growing list of jurisdictions that opt to legitimize weed and reap the sales tax benefits.

How this patchwork of regulatory acceptance unfolds holds strategic advantages for certain companies, something that investors in the sector should keep an eye on.

Take the latest report from financial analysis firm Cantor Fitzgerald as an example. Last week, it released a report that suggested five more states will likely legalize recreational cannabis in the next two years—Arizona, New Jersey, New York, Pennsylvania and Connecticut. Given the size of the populations of these states, the report went on to estimate that, combined, these five will expand the US cannabis market by approximately $3.5 billion.

This, according to the Cantor analysis, would give three companies with footprints in those states a strategic advantage to best take advantage of the legislation moves—Curaleaf Holdings (OTC:CURLF) (CSE:CURA), Green Thumb Industries (OTC:GTBIF) (CSE:GTII) and Cresco Labs (OTC:CRLBF) (CSE:CL).

They would not be the only beneficiaries. But let’s look at them first.

According to reports of the Cantor study, Curaleaf is positioned to expand operations in all five states. Also, last week, the Massachusetts-based grower, which is the largest vertically integrated cannabis operator in the United States, announced it struck a deal to acquire GR Companies, also commonly known as Grassroots, the largest privately-owned, vertically-integrated multi-state operator in the US. The deal will make Curaleaf the largest cannabis company by revenue in the US.

Curaleaf Holding shares gained about 2.5% at the end of last week on the news, but added to that yesterday, rising 7.6% on the day to close at $8.02

Curaleaf Holding OTC Shares
Curaleaf Holding OTC Shares

Curaleaf CEO Joseph Lusardi said the following in a statement about the acquisition:

“The successful acquisition of Grassroots marks Curaleaf’s expansion into new vertically integrated markets in the Midwest, firmly establishing our US market leadership position.”

The deal accelerates Curaleaf’s expansion into Illinois and Pennsylvania, which are among the largest and fastest-growing cannabis markets in the United States.

It also gives it licensed presence in Arizona, Connecticut, Florida, Illinois, Pennsylvania, Maryland, Massachusetts, Maine, Nevada, New Jersey, New York, North Dakota and Vermont.

As for Green Thumb Industries, the Cantor report predicts expanded legalization could lead it to double its sales.

The Chicago-based medicinal and recreational cannabis grower has seen its stock mount a steady rise throughout the month of July, gaining more than 33%. Yesterday, the shares gained just over 5% on the day to close at $12.82.

While over at Cresco Labs, which already operates in Pennsylvania, New York and Arizona, the Cantor Fitzgerald report claims it could see its sales figures double as well.

Aphria Sees Share Boost Before Results

Shares of Aphria (NASDAQ:APHA) (TSX:APHA) jumped about 12% on Monday in both Toronto and New York. Its performance on the Canadian exchange earned it the title of the best performer on S&P/TSX Composite on the day. The boost comes just two days before the Ontario-based cannabis grower reports its fourth-quarter earnings.

NASDAQ Aphria Shares
NASDAQ Aphria Shares

In the previous quarter, Aphria reported it about doubled its net revenues from the same period in the previous year, hitting just over C$144 million ($107.6 million) compared with C$73.6 million the year prior.

Aside from the fiscal performance during the early part of the pandemic, company executives will likely be quizzed on future plans, following reports earlier this month that merger talks with Aurora Cannabis (NYSE:ACB) (TSX:ACB) hit the skids.

Shares of Aphria yesterday gained 12.33% to closed at $5.74 on the NASDAQ, while adding 11.95% on the Toronto exchange to close at C$7.68.

3 Pot Growers Poised To Profit From The State-By-State March To Legalization
 

Related Articles

Scarlett Smith
10 Hot Canadian Penny Stocks To Buy in April By Scarlett Smith - Apr 01, 2021

Potential high returns and a relatively lower price make penny stocks an appealing option for people looking to invest their money in the stock market. However, these stocks come...

3 Pot Growers Poised To Profit From The State-By-State March To Legalization

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email